<?xml version="1.0" encoding="UTF-8"?>
<ref id="B103-molecules-24-02155" class="ref">
 <label class="label">103.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Shangguan</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Qi</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lu</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wu</surname>
    <given-names class="given-names">W.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: Implications on the contribution of integral structure</article-title>
  <source class="source">Int. J. Pharm.</source>
  <year class="year">2015</year>
  <volume class="volume">489</volume>
  <fpage class="fpage">195</fpage>
  <lpage class="lpage">202</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.ijpharm.2015.05.005</pub-id>
  <?supplied-pmid 25956049?>
  <pub-id pub-id-type="pmid" class="pub-id">25956049</pub-id>
 </element-citation>
</ref>
